Zdrowie i gospodarka · 03/01/2013

FDA Announces Draft Guidance for Electronic Regulatory Submissions for Human Pharmaceutical Products

The FDA is releasing a draft guidance outlining how it plans to implement electronic submissions for certain human pharmaceutical product applications, in accordance with the FDASIA Act, with public comment period to begin after a 2-year review period following the document's final publication.